Viking Therapeutics (1VT) Short Interest
DB • 1VT • US92686J1060
As of Oct 22, 2026, ORTEX estimated 7% of free float sold short, 12,787.7 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
DB • 1VT • US92686J1060
As of Oct 22, 2026, ORTEX estimated 7% of free float sold short, 12,787.7 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
This page tracks how heavily Viking Therapeutics (DB:1VT) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Viking Therapeutics (DB: 1VT) has a market capitalization of $3.42B. Last close €23.75 (as of 2026-11-09); 52-week range €21.35 to €38.00. ORTEX data as of 2026-10-22: short interest was 7.04% of free float, 12,787.7 days to cover and the average cost to borrow was 0.49%. Sign up for live short interest data.